$AME

Billionaire Mario Gabelli Has Held AMETEK (AME) for Over a Decade. Is the Stock Still a Buy?

AMETEK (AME) is a top holding of Mario Gabelli's GAMCO Investors, with a $131.7M stake. The company, which makes sensors and instruments, trades at a forward P/E of 29.7. Analysts expect 12.5% EPS growth in 2026 and 14% in 2027. Recent earnings showed 15% sales growth and 17% EPS growth, with a record order backlog. Management raised full-year guidance but expects slower growth in the second half.

Original reporting
Published Oct 12, 2026, 1:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 12, 2026, 1:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Billionaire Mario Gabelli Has Held AMETEK (AME) for Over a Decade. Is the Stock Still a Buy? — source image
Decision brief

The 30-second read

$AMEBullishLow
01

Why it matters

The only actionable elements are the cited latest-quarter performance, record backlog, and raised full-year guidance, which can influence near-term expectations for industrial instrumentation demand and earnings trajectory.

02

Market read

Traders get a fundamentals snapshot and guidance directionality (raised full-year, slower 2H organic growth), but the piece is not a first-report catalyst.

03

What to watch

No discussion of margin trajectory, competitive pricing pressure, customer capex timing risk, or integration execution risk beyond a generic bear-case mention.

Relevance 4/10Novelty 3/10Timing: no specific pre/post-market catalyst; general investment thesis published today

Background

Gabelli’s GAMCO Investors has held AMETEK since Q4 2013, trimming the stake through end-2025, and the article evaluates valuation versus growth assumptions.

Company-level read

Ticker impact

$AMEBullishMedium confidence
Context

Article frames AMETEK as a long-held Gabelli position and cites latest-quarter strength plus raised full-year guidance and record backlog.

Expected impact

Likely supportive near-term sentiment as investors focus on raised guidance and backlog strength, partially offset by expectations for slower second-half organic growth.

Evidence & confidence

The piece is primarily an investor-profile/valuation discussion, but it includes concrete, company-specific datapoints: sales and EPS growth, orders and record backlog, and raised full-year guidance with mid-to-high single-digit organic growth in the second half.

Market effects

Supports the broader industrial instrumentation/sensors narrative that demand is resilient across data centers, chipmaking, aircraft, and grid upgrades.

No explicit regional macro linkage beyond general industrial demand.

Limited; demand drivers cited are global end-markets but no country-specific policy or supply shock is introduced.

Counterpoint

The article may over-weight a single strong quarter and backlog record while under-emphasizing the guidance signal of slower organic sales growth in the second half.

Key entities

  • AMETEK

    US-listed industrial instrumentation and sensors company discussed as the article’s subject.

  • GAMCO Investors

    Gabelli’s fund cited as holding a stake in AMETEK.

  • TCW

    Referenced as adding AMETEK in Q4 2025.

Related articles

$AMEMedAI 9/10

AMETEK’s (AME) $5B Deal Bets Big On A Hot Streak

AMETEK (AME) completed a $5.0B cash acquisition of Indicor Instrumentation. The company reported record Q2 sales of $2.04B, up 15% YoY, and raised full-year guidance. Indicor is expected to add $350M to 2026 sales and be modestly accretive to earnings. The deal aligns with AMETEK's existing portfolio and markets.

$RIMEMed

Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75

Carets Corp is exploring a potential sale, including its technology and patents. Algorhythm Holdings (RIME) and Biomerica (BMRA) are evaluating strategic alternatives. nVent Electric (NVT) acquired Maverick Power for $1.75B, with up to $550M more in performance-based payments. Descartes (DSGX) bought Tai for $100M, and Navitas (NVTS) acquired Claros for up to $232.8M. Booz Allen (BAH) completed a $720M acquisition, and Elastic (ESTC) acquired Deductive AI. BioXcel (BTAI) filed for Chapter 11 ban

$AMEHighAI 9/10

AMETEK Completes Acquisition of Indicor Instrumentation

AMETEK, Inc. (NYSE: AME) completed its $5.0 billion acquisition of Indicor Instrumentation. The deal adds businesses that design and manufacture mission-critical industrial and scientific solutions. Indicor Instrumentation is expected to contribute $350 million to AMETEK's 2026 sales and be modestly accretive to earnings. The acquisition aligns with AMETEK's growth strategies and market focus.

$AMEHighAI 9/10

AMETEK Raises 2026 Outlook After Earnings Climb 17%

AMETEK (NYSE: AME) raised its 2026 outlook after Q2 results. Second-quarter adjusted earnings rose 17% to $2.09 per diluted share, with sales up 15% to $2.04 billion and orders up 28%. AMETEK now expects 2026 adjusted earnings of $8.20 to $8.30 per share and sales up about 10% from 2025.